Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05792566

ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer

Development and Usability Testing of the ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Children, Adolescent and Young Adults (AYA) survivors of childhood cancer

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

10 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Connecticut Children's Medical Center

Hartford, Connecticut, 06106, United States

About this study

The purpose of this program of research is to (1) determine the adaptations required of a pre-existing mobile fitness app to tailor it for childhood cancer survivors using a behavioral theory driven approach (Social Cognitive Theory) and (2) develop and evaluate the usability of the adapted mobile app using the Technology Assessment Model. The Technology Assessment Model (TAM), which theorizes the individuals' intentions to use information technology, is based on two driving factors: perceived usefulness and perceived ease of use. Future studies will evaluate the feasibility and effectiveness of this app.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children, adolescent and young adults (AYA) ages 10 to 30 years
  • diagnosis with a pediatric cancer diagnosis that requires the treatment of anthracycline therapy
  • Able to speak English fluently (App currently only in English at this time)

Exclusion criteria

  • Pediatric cancer survivors who will not be treated with anthracycline therapy
  • Unable to cooperate with interviewing
  • Unable to understand the content of interviews
  • Non-English speaking

Treatment and study plan

Atomic app

Other

Using the Atomic app to improve physical activity

Primary outcomes

  1. Ease of use and user errors will be documented for each individual during usability testing, by completing several tasks while navigating the mobile app platform

    Time frame: 1 year

    The interviewers will record how well the participants are able to navigate the task by recording either "easy to find", "with prompting", or "unable to complete", representing completing the task completely on their own, with help from the interviewer, or unable to complete after prompting from the interviewer. The frequency of user errors will be calculated.

  2. The Acceptability E-Scale is six-item tool that has been validated for assessing the usability, acceptability, and satisfaction of web based programs with statements ranked on a five point scale from very difficult to very easy

    Time frame: 1 year

    Acceptability of a program has been proposed to be represented by obtaining a score of 24 or more.81 Good internal consistency (alpha = 0.76) as well as good initial validity has been reported. The acceptability E-scale will be administered at the completion of the "in laboratory" testing and "real-life" usability testing.

Sponsors and collaborators

Lead sponsor

Connecticut Children's Medical Center

Other

Collaborators

  • The Hospital for Sick Children

Registry information

Official study title

Development and Usability Testing of the ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Children, Adolescent and Young Adults (AYA) Survivors of Childhood Cancer

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Mar 31, 2023
Registry last updated
Jan 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.